High-level generation of polyclonal antibodies by genetic immunization

被引:77
作者
Chambers, RS [1 ]
Johnston, SA [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Ctr Biomed Invent, Dallas, TX 75390 USA
关键词
D O I
10.1038/nbt858
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antibodies are important tools for investigating the proteome, but current methods for producing them have become a rate-limiting step(1). A primary obstacle in most methods for generating antibodies or antibody-like molecules is the requirement for at least microgram quantities of purified protein. We have developed a technology for producing antibodies using genetic immunization(2). Genetic immunization-based antibody production offers several advantages, including high throughput(3) and high specificity. Moreover, antibodies produced from genetically immunized animals are more likely to recognize the native protein(2). Here we show that a genetic immunization-based system can be used to efficiently raise useful antibodies to a wide range of antigens. We accomplished this by linking the antigen gene to various elements that enhance antigenicity and by codelivering plasmids encoding genetic adjuvants. Our system, which was tested by immunizing mice with >130 antigens, has shown a final success rate of 84%.
引用
收藏
页码:1088 / 1092
页数:5
相关论文
共 29 条
[11]   QUALITY-CONTROL IN THE SECRETORY PATHWAY [J].
HAMMOND, C ;
HELENIUS, A .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (04) :523-529
[12]  
JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181
[13]   DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma [J].
King, CA ;
Spellerberg, MB ;
Zhu, DL ;
Rice, J ;
Sahota, SS ;
Thompsett, AR ;
Hamblin, TJ ;
Radl, J ;
Stevenson, FK .
NATURE MEDICINE, 1998, 4 (11) :1281-1286
[14]   Protein microarrays: prospects and problems [J].
Kodadek, T .
CHEMISTRY & BIOLOGY, 2001, 8 (02) :105-115
[15]   Initial sequencing and analysis of the human genome [J].
Lander, ES ;
Int Human Genome Sequencing Consortium ;
Linton, LM ;
Birren, B ;
Nusbaum, C ;
Zody, MC ;
Baldwin, J ;
Devon, K ;
Dewar, K ;
Doyle, M ;
FitzHugh, W ;
Funke, R ;
Gage, D ;
Harris, K ;
Heaford, A ;
Howland, J ;
Kann, L ;
Lehoczky, J ;
LeVine, R ;
McEwan, P ;
McKernan, K ;
Meldrim, J ;
Mesirov, JP ;
Miranda, C ;
Morris, W ;
Naylor, J ;
Raymond, C ;
Rosetti, M ;
Santos, R ;
Sheridan, A ;
Sougnez, C ;
Stange-Thomann, N ;
Stojanovic, N ;
Subramanian, A ;
Wyman, D ;
Rogers, J ;
Sulston, J ;
Ainscough, R ;
Beck, S ;
Bentley, D ;
Burton, J ;
Clee, C ;
Carter, N ;
Coulson, A ;
Deadman, R ;
Deloukas, P ;
Dunham, A ;
Dunham, I ;
Durbin, R ;
French, L .
NATURE, 2001, 409 (6822) :860-921
[16]   Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences [J].
Li, ZM ;
Howard, A ;
Kelley, C ;
Delogu, G ;
Collins, F ;
Morris, S .
INFECTION AND IMMUNITY, 1999, 67 (09) :4780-4786
[17]  
NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
[18]   Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing [J].
Pizza, M ;
Scarlato, V ;
Masignani, V ;
Giuliani, MM ;
Aricò, B ;
Comanducci, M ;
Jennings, GT ;
Baldi, L ;
Bartolini, E ;
Capecchi, B ;
Galeotti, CL ;
Luzzi, E ;
Manetti, R ;
Marchetti, E ;
Mora, M ;
Nuti, S ;
Ratti, G ;
Santini, L ;
Savino, S ;
Scarselli, M ;
Storni, E ;
Zuo, PJ ;
Broeker, M ;
Hundt, E ;
Knapp, B ;
Blair, E ;
Mason, T ;
Tettelin, H ;
Hood, DW ;
Jeffries, AC ;
Saunders, NJ ;
Granoff, DM ;
Venter, JC ;
Moxon, ER ;
Grandi, G ;
Rappuoli, R .
SCIENCE, 2000, 287 (5459) :1816-1820
[19]   Genetic adjuvants for DNA vaccines [J].
Scheerlinck, JPY .
VACCINE, 2001, 19 (17-19) :2647-2656
[20]  
Smith C, 1993, PCR Methods Appl, V2, P328, DOI 10.1101/gr.2.4.328